General Screening and Anticoagulant Testing

Broad assay menu for tailored testing 
HemosIL PT reagents offer consistent performance sensitivity to enable optimal monitoring of oral anticoagulant therapy and evaluation of the extrinsic coagulation pathway.  Highly stable and always consistent for moderate to high sensitivity.  HemosIL APTT reagents enable optimal monitoring of therapeutic coagulation inhibitors and screening of the intrinsic coagulation pathyway with excellent sensitivity and lot-to-lot consistency.  The General Screening Panel also includes Fibrinogen assays to assess bleeding risk in patients with unexplained prolonged PT or APTT results.
Consistency, test after test, for optimal efficiency.